Manual Antimicrobial Susceptibility Test Systems

Home/Specialty/Microbiology/Manual Antimicrobial Susceptibility Test Systems

Manual Antimicrobial Susceptibility Test Systems

Main Filters

Manual Antimicrobial Susceptibility Test Systems

BIOMERIEUX SA
CATALOG #	QTY	PRICE	DESCRIPTION
559802	0	-	The Simplex instrument automates placement of up to 6 different Etest strips from foam packaging directly onto agar plates.
Etest® AMIKACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® AMOXICILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ampicillin/sulbactam (2/1) (AB)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Azithromycin (AZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Aztreonam (AT)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® BENZYLPENICIL	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Benzylpenicillin (PG)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cefepime (PM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOTAXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOTAXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOTETAN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cefoxitin (FX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ceftaroline (CPT)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTAZIDIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTRIAXONE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTRIAXONE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFUROXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CHLORAMPHENICOL	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ciprofloxacin (CI)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CLINDAMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ERTAPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Erythromycin (EM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)	0	-	Etest is a quantitative technique for determining the MIC of antimicrobial agents against microorganisms and for detection of resistance mechanisms.
ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)	0	-	Etest is a quantitative technique for determining the MIC of antimicrobial agents against microorganisms and for detection of resistance mechanisms.
ETEST® Fosfomycin (FM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Gentamicin (GM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Gentamicin (GM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® IMIPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Imipenem/Relebactam (IPR)	0	-	ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria.
Etest® MEROPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® MEROPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Minocycline (MC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® OFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TIGECYCLINE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TOBRAMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Ortho Development Corporation
CATALOG #	QTY	PRICE	DESCRIPTION
561-5231	0	-	Femoral Sleeve 31mm M-L 22mm A-P
561-5234	0	-	Femoral Sleeve 34mm M-L 22mm A-P
561-5240	0	-	Femoral Sleeve 40mm M-L 22mm A-P
561-5246	0	-	Femoral Sleeve 46mm M-L 22mm A-P
561-5252	0	-	Femoral Sleeve 52mm M-L 22mm A-P
561-5258	0	-	Femoral Sleeve 58mm M-L 22mm A-P
562-0001	0	-	Tibial Tray Keel Cap
562-5252	0	-	Tibial Sleeve 52mm M-L 31mm A-P
562-5260	0	-	Tibial Sleeve 60mm M-L 33mm A-P
562-5268	0	-	Tibial Sleeve 68mm M-L 36mm A-P

REMEL, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
CP112-10	0	-
CP114-10	0	-
T3462-10	0	-
T3470	0	-	Sensititre HTM Broth

626 Results

Results Per Page

Catalog #

AvailableQty

Starting At

Name

Company Name

Description

Etest® OFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Minocycline (MC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® MEROPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® IMIPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Gentamicin (GM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Erythromycin (EM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CLINDAMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ciprofloxacin (CI)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CHLORAMPHENICOL

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFUROXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTAZIDIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTRIAXONE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTRIAXONE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cefoxitin (FX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOTAXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOTAXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cefepime (PM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Benzylpenicillin (PG)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® BENZYLPENICIL

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ampicillin/sulbactam (2/1) (AB)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Aztreonam (AT)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Azithromycin (AZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMIKACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMOXICILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ceftaroline (CPT)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TIGECYCLINE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TOBRAMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)

BIOMERIEUX SA

Etest is a quantitative technique for determining the MIC of antimicrobial agents against microorganisms and for detection of resistance mechanisms.

ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)

BIOMERIEUX SA

Etest is a quantitative technique for determining the MIC of antimicrobial agents against microorganisms and for detection of resistance mechanisms.

Etest® ERTAPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Fosfomycin (FM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® MEROPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Gentamicin (GM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOTETAN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

559802

Applicator - Simplex C76

BIOMERIEUX SA

The Simplex instrument automates placement of up to 6 different Etest strips from foam packaging directly onto agar plates.

ETEST® Imipenem/Relebactam (IPR)

BIOMERIEUX SA

ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria.

T3462-10

REMEL, INC.

T3470

REMEL, INC.

Sensititre HTM Broth

CP114-10

REMEL, INC.

CP112-10

REMEL, INC.

562-0001

Balanced Knee Revision System

Ortho Development Corporation